Literature DB >> 20846034

Clinical management of acute HIV infection: best practice remains unknown.

Sigall K Bell1, Susan J Little, Eric S Rosenberg.   

Abstract

Best practice for the clinical management of acute human immunodeficiency virus (HIV) infection remains unknown. Although some data suggest possible immunologic, virologic, or clinical benefit of early treatment, other studies show no difference in these outcomes over time, after early treatment is discontinued. The literature on acute HIV infection is predominantly small nonrandomized studies, which further limits interpretation. As a result, the physician is left to grapple with these uncertainties while making clinical decisions for patients with acute HIV infection. Here we review the literature, focusing on the potential advantages and disadvantages of treating acute HIV infection outlined in treatment guidelines, and summarize the presentations on clinical management of acute HIV infection from the 2009 Acute HIV Infection Meeting in Boston, Massachusetts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846034      PMCID: PMC6037306          DOI: 10.1086/655655

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  74 in total

1.  Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.

Authors:  L Al-Harthi; J Siegel; J Spritzler; J Pottage; M Agnoli; A Landay
Journal:  AIDS       Date:  2000-05-05       Impact factor: 4.177

2.  Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.

Authors:  Hendrik Streeck; Heiko Jessen; Galit Alter; Nickolas Teigen; Mike T Waring; Arne Jessen; Ingrid Stahmer; Jan van Lunzen; Mathias Lichterfeld; Xiaojiang Gao; Todd M Allen; Mary Carrington; Bruce D Walker; Juergen K Rockstroh; Marcus Altfeld
Journal:  J Infect Dis       Date:  2006-08-15       Impact factor: 5.226

3.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Authors:  Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

4.  Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection.

Authors:  A Lafeuillade; C Poggi; C Tamalet; N Profizi; C Tourres; O Costes
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

5.  A controlled trial of zidovudine in primary human immunodeficiency virus infection.

Authors:  S Kinloch-De Loës; B J Hirschel; B Hoen; D A Cooper; B Tindall; A Carr; J H Saurat; N Clumeck; A Lazzarin; L Mathiesen
Journal:  N Engl J Med       Date:  1995-08-17       Impact factor: 91.245

6.  Transmission of drug-resistant HIV-1 is stabilizing in Europe.

Authors:  Jurgen Vercauteren; Annemarie M J Wensing; David A M C van de Vijver; Jan Albert; Claudia Balotta; Osamah Hamouda; Claudia Kücherer; Daniel Struck; Jean-Claude Schmit; Birgitta Asjö; Marie Bruckova; Ricardo J Camacho; Bonaventura Clotet; Suzie Coughlan; Zehava Grossman; Andrzej Horban; Klaus Korn; Leondios Kostrikis; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Elisabeth Puchhammer-Stöckl; Chiara Riva; Lidia Ruiz; Mika Salminen; Rob Schuurman; Anders Sonnerborg; Danica Stanekova; Maja Stanojevic; Anne-Mieke Vandamme; Charles A B Boucher
Journal:  J Infect Dis       Date:  2009-11-15       Impact factor: 5.226

7.  Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

Authors:  Diane E Bennett; Ricardo J Camacho; Dan Otelea; Daniel R Kuritzkes; Hervé Fleury; Mark Kiuchi; Walid Heneine; Rami Kantor; Michael R Jordan; Jonathan M Schapiro; Anne-Mieke Vandamme; Paul Sandstrom; Charles A B Boucher; David van de Vijver; Soo-Yon Rhee; Tommy F Liu; Deenan Pillay; Robert W Shafer
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

8.  Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.

Authors:  Susan J Little; Simon D W Frost; Joseph K Wong; Davey M Smith; Sergei L Kosakovsky Pond; Caroline C Ignacio; Neil T Parkin; Christos J Petropoulos; Douglas D Richman
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

9.  Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection.

Authors:  Sigall Kassutto; Kaveh Maghsoudi; Mary N Johnston; Gregory K Robbins; Nicole C Burgett; Paul E Sax; Daniel Cohen; Eunice Pae; Ben Davis; Kimon Zachary; Nesli Basgoz; Erika M C D'agata; Victor DeGruttola; Bruce D Walker; Eric S Rosenberg
Journal:  Clin Infect Dis       Date:  2006-02-27       Impact factor: 9.079

10.  Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?

Authors:  Cécile Goujard; Marie-Laure Chaix; Olivier Lambotte; Christiane Deveau; Martine Sinet; Julien Guergnon; Valérie Courgnaud; Christine Rouzioux; Jean-François Delfraissy; Alain Venet; Laurence Meyer
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

View more
  18 in total

1.  Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection.

Authors:  Maile Y Karris; Yu-ting Kao; Derek Patel; Matthew Dawson; Steven P Woods; Florin Vaida; Celsa Spina; Douglas Richman; Susan Little; Davey M Smith
Journal:  AIDS       Date:  2014-03-27       Impact factor: 4.177

2.  Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland.

Authors:  Yen T Duong; Yvonne Mavengere; Hetal Patel; Carole Moore; Julius Manjengwa; Dumile Sibandze; Christopher Rasberry; Charmaine Mlambo; Zhi Li; Lynda Emel; Naomi Bock; Jan Moore; Rejoice Nkambule; Jessica Justman; Jason Reed; George Bicego; Dennis L Ellenberger; John N Nkengasong; Bharat S Parekh
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

3.  Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.

Authors:  Nora E Rosenberg; Gift Kamanga; Sam Phiri; Dominic Nsona; Audrey Pettifor; Sarah E Rutstein; Deborah Kamwendo; Irving F Hoffman; Maria Keating; Lillian B Brown; Beatrice Ndalama; Susan A Fiscus; Seth Congdon; Myron S Cohen; William C Miller
Journal:  J Infect Dis       Date:  2011-12-29       Impact factor: 5.226

4.  The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

Authors:  Christine M Hogan; Victor Degruttola; Xin Sun; Susan A Fiscus; Carlos Del Rio; C Bradley Hare; Martin Markowitz; Elizabeth Connick; Bernard Macatangay; Karen T Tashima; Beatrice Kallungal; Rob Camp; Tia Morton; Eric S Daar; Susan Little
Journal:  J Infect Dis       Date:  2011-12-15       Impact factor: 5.226

5.  The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study.

Authors:  Kimberly A Powers; Azra C Ghani; William C Miller; Irving F Hoffman; Audrey E Pettifor; Gift Kamanga; Francis Ea Martinson; Myron S Cohen
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

6.  Central nervous system viral invasion and inflammation during acute HIV infection.

Authors:  Victor Valcour; Thep Chalermchai; Napapon Sailasuta; Mary Marovich; Sukalaya Lerdlum; Duanghathai Suttichom; Nijasri C Suwanwela; Linda Jagodzinski; Nelson Michael; Serena Spudich; Frits van Griensven; Mark de Souza; Jerome Kim; Jintanat Ananworanich
Journal:  J Infect Dis       Date:  2012-05-02       Impact factor: 5.226

7.  Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation.

Authors:  Michael J Vinikoor; Anna Cope; Cynthia L Gay; Guido Ferrari; Kara S McGee; Joann D Kuruc; Jeffrey L Lennox; David M Margolis; Charles B Hicks; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

Review 8.  Acute HIV-1 Infection.

Authors:  Myron S Cohen; George M Shaw; Andrew J McMichael; Barton F Haynes
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245

9.  Short-course antiretroviral therapy in primary HIV infection.

Authors:  Sarah Fidler; Kholoud Porter; Fiona Ewings; John Frater; Gita Ramjee; David Cooper; Helen Rees; Martin Fisher; Mauro Schechter; Pontiano Kaleebu; Giuseppe Tambussi; Sabine Kinloch; Jose M Miro; Anthony Kelleher; Myra McClure; Steve Kaye; Michelle Gabriel; Rodney Phillips; Jonathan Weber; Abdel Babiker
Journal:  N Engl J Med       Date:  2013-01-17       Impact factor: 91.245

10.  Challenges of diagnosing acute HIV-1 subtype C infection in African women: performance of a clinical algorithm and the need for point-of-care nucleic-acid based testing.

Authors:  Koleka Mlisana; Magdalena Sobieszczyk; Lise Werner; Addi Feinstein; Francois van Loggerenberg; Nivashnee Naicker; Carolyn Williamson; Nigel Garrett
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.